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1.0 Introduction
1.1 Purpose of Contract
The primary purpose of this contract is to develop a low dose neutron
activation technique to measure total body calcium (TBC) in-vivo. The
effort has included development of irradiation and processing facilities
and conduction of human studies to determine the accuracy and precision of
measurement attainable with the systems.
The primary motivation for the development of the technique was to
provide a meLns to serially quantitate charges in total body calcium during
long-term zero-g conditions and simultations of zero-g conditions (i.e. bed-
rest studies). The technique would also provide needed information in the
study and management of metabolic bone disease such as osteoporosis.
1.2 Basis of Technique
TBC systems using total body neutron irradiation had already been
developed at the time this contract was initiated. However, these systems,
all based on slow neutron capture by 48 Cato form 
49 
Ca, require a patient
dose of 100-200 mrads (1-4). H.E. Palmer noted that 40 Cawas about 500
times more abundant and thus if a suitable reaction involving 
40 
Cacould be
found, TBC measurements at significant lower doses might be possible.
The fast (n,a) reaction on 40 Cato produce the radioactive gas 37Ar,
which in turn would be excreted through the lungs, became the reaction of
interest. During in-vivo neutron irradiation, 37 A can only be produced from
40 Ca. Argon-37 decays by Auger electron emission (2.62 KeV) with a half-
life of 35 days (Figure 1). The only other isotope of argon produced is 41 A
which is produced in less quantity than the 37 A and is prevented from causing
any interference during counting due to the short 1.8 hour half-life (5) (the
41 A decays away prior to counting the sample).
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H.E. Palmer performed animal studies to determine the basic feasi-
bility of a 37 A TBC system. In rats, TBC was measured with an absolute
accuracy of + 3% (6). These data also suggested that measurements of total
body calcium in humans could be obtained with a neutron exposure of 10 mrad
or less. These observations lead directly to the effort summarized in this
It
report.
1.3
	
System Overview
The technique is based on collecting 37 A exhaled in the breath
following a uniform total body irradiation by 14 MeV neutrons. The 37 A
in the exhaled breath, which is directly proportional to TBC, is extracted
and the radioactivity is quantitated in a low-background proportional detector
system. The systems developed for human studies at the University of Washington
are, for the most part, based on the systems originally described for animal
0	 studies by N.E. Palmer (6).
The 37 A technique involves the use of four systems: 1) the irradiation
facility consisting of the 14 MeV neutron generator and the patient enclosure;
2) the gas collection system consisting of a closed-circuit breathing system
and sampling cylinders; 3) the gas purification system which isolates the
argon in the breath sample using selective absorption; and 4) the argon-37
counting system consisting of low-background proportional detectors with
appropriate shielding and counting electronics.
As discussed in other sections of this report, the systems currently in
operation ,-ovide an activation uniformity of + 2.7% and an accuracy of
measurement of at least + 5.51 and a precision of measurement of + 2.7% with
a total patient dose of 10 mrads.
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2.0 Activation Facility
Q2.1
	
Description of Facility
The basic facility is diagrammed in Figure 2, and consists of a 14 Mev
neutron generator, a patient enclosure, dose monitors, a dose control system
interfaced to the neutron generator control system, and necessary shielding.
The neutron generator is a Kaman Model A-711 producing =5 x 1010
neutrons/second into 4 H steroidions. The generator head is enclosed in a
"pillbox" made up of high density concrete blocks (7). The exit part of the
"pillbox" is equipped with a collimator (Fig. 2) made from borated water-
extended resin. The collimator limits the area of the direct beam to a
rectangle approximately 300 cm high and 250 cm wide at the patient position.
To provide optimal uniformity of 
40 
Caactivation to all parts of the
body and to allow for different body sizes, the patient enclosure was
de _fined such that the patient is surrounded with water, keeping the total
volume of the enclosure constant. A rectangular tank, 60.9 cm x 30.5 cm x
198 cm was made from 1/4" thick aluminum plate (Fig. 3). An adjustable lucite
platform inside the tank allows the patient's shoulders to be positioned just
below the top of the tank. The tank is mounted on top of a turntable to allow
bilateral irradiation.
The radiation dose delivered to the patient is monitored during irradia-
tion by two devices, a tissue-equivalent ion chamber and a LiI scintillator.
The ion chamber, an 80 cc EG&G device used with a constant 5 ml/min. flow of
tissue equivalent gas is used to turn off the neutron generator at a preset
value (7). The dosimeters were calibrated against similar dosimeters used
for neutron irradiation at the University of Washington cyclotron facility (8).
Measurements with a graphite ion chamber indicate that the neutrons account for
	 °1'
more than 90% of the 10 mrad patient dose
	 I
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2.2
	
Activation Uniformity
The uniformity of the neutron field in air was measured at the surface
of the patient irradiation position by irradiating a series of aluminum
pellets, 0.64 cm in diameter and 1.27 cm long, suspended in a grid pattern.
The relative fast neutron flux 'was measured using the 27A]. (n,a) 24 N
reaction. The results are shown in Figure 4. Except for positions within
50 cm of the concrete floor, the flu:: distribution varied only by + 2% over
an area 203 cm x 203 cm, consistent with the expected 1/r 2 distribution (5).
The activation uniformity inside the water filled tank was measured by
irradiating vials filled with calcium nitrate solutions and quantitating the
37
.;r produced. The 10 ml borisilicate glass vials were filled with a solution
of 100 g of Ca(NO 3 ) • 4H2O per 100 ml water. forty-five vials were positioned
on three planes within the enclosure, such that both the center and sides of
each plane were sampled at several depths. The vials were irradiated simul-
taneously (Fig. 5). Each vial was then remuved and placed inside a gas tight
container consisting of a 12 inch long, 1 inch I.D. tygon tube iitted with
lucite end plates and containing 30 ml of water. The vial was broken and
the 37 A removed by bubbling helium through the container and routing the
gas through the argon purification system described below. The 37 A from
each vial was then quantitated in a low-background proportional detector.
The results, as well as similar data obtained independently by Palmer
(Palmer, Private Communication), are shown in Figure 6. For a bilateral
irradiation, the uniformity of activation inside the water-filled enclosure
was + 2.7%, providing a trean yield of 1.21 pCi of 37Ar/g calcium per mrad
dose.
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2.3
	
Discussion
For TBC studies, the patient is positioned in the tank, the door is
sealed, and the tank is filled with lukewarm water. The face mask of the gas
collection s ystem is installed and then the bilateral irradiation is carried
out (the turntable is rotated manually between the irradiations). The water
is then removed using the large drain valve at the bottom of the tank, the
patient dries off and dresses (wearing the face mask at all times) and is
transported to a waiting room for the remainder of the breath collection
period. The typical irradiation time, including the rotation of the enclosure,
is four minutes.
The uniformity of activation for the 37 A TBC system is excellent,
significantly bitter than the uniformity attainable in 49Ca studies (7). The	
I
I
activation uniformity measured in our laboratories is generally better than
has been reported for 37 A studies at other laboratories using neutron beams
frt.-. cyclotrons (9). However, since neutron beams produced from cyclotrons
have a fairly wide energy spread width, a large portion of the neutron energies
are near the rapid decrease in the (n,a) reaction cross section (Figure 7),
a greater fall-off of activation with depth for cyclotron based irradiation
facilities is to be expected.
For final data analysis, a precise comparator standard must be irrad-
iated with the patient. This standard corrects all measurements for any
differences in neutron fluence. The standard consists of a set of four 	 i.^
aluminum disks, each 22.9 cm in diameter and 0.64 cm thick, positioned at 	 j
the corners of a rectangle, 91 cm x 198 cm, centered around the patient 	 j
enclosure. After each patient irradiation, the 
24 
Naproduced in the disks
by the 27 A (n,a) reaction is cuantitated with the use of two opposing 9"
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diameter x 4" thick NaI(T1) detectors. Typically 10 5 counts from 24 Naare
obtained during a 1000 s.cond counting period at four hours post irradiation.
3.0 Gas Collection System
3.1	 Description of System
During the early feasibility studies, several breath collection systems
were studied. The systems all had two basic features. First, to reduce
nitrogen in the breath and hence reduce processing time in the purification
system, the patient is maintained on a 25% 0 2 - 75% He atmosphere for five
minutes prior to and during breath collection. Second, the 37Ar, as well as
11	 other gases, are trapped on Type 5A molecular sieve material cooled by liquid
nitrogen at the end of the breath collection period.
In early systems, the 0 2-He was continuously fed to the system and the
patient's breath was collected without any recirculation. Because of the
large volumes, these systems could hold breath samples of only 10-15 minutes.
After the first 37 A excretion rate studies, it became desirable to collect
samples of 1-3 hours in length and a closed-circuit system was designed (Fig. 8).
The exhaled breath is recirculated, Co 2 is removed and 0 2 is replaced as
needed. Thus, the total volume of gas collected in each sample is a constant,
independent of the amount of time the system is in use. The system includes
an expansion bellows, the position of which is monitored by two reed relays
which are used to open and close a solenoid valve to the oxygen supply, a
circulating fan to reduce back pressure and keep a constant flow of air moving
across the face plate of the mask, a soda lime cannister to absorb CO2 , bacterial
filters and vale	 to allow the system to be flushed with 0 2-He or pat on closed-
circuit operation. The rebreather is installed underneath a reclining wheel-
chair and the power is supplied by a 12-volt battery and charger system, making
I ^^
	
the entire system self-contained and mobile.
fl
ON
v
3
v
N
Z
•	 J
O
_EJ
v
O
0
U
N
30
O
m
v 
cv
^LUi
c0
M
LLJ
H
Z
O
U
W
J
JOU
Q
C^
O v
c
a^
0 0
to >
^ O
^ m
0
^O
C
C O
075
=c O
a 0 0N`
0 
U
0 0O —
m >
a
E
a
E
U
>
U-
L.O
C C)
O
O
``
	 Z CD
I	 cc
C rA
ON ^
Oc
M Op^-
Figure 8
AL p pG ,CRIGIN 
	
Ic
OF P
puvt ^U AI,ITY
- 7 -
After the desired breath collection period has ended, the system is
flushed with 0 2-Ile and the exhaust is routed into a 100 liter Douglas bag.
The gas in the Douglas bag is pumped through a 4 liter stainless steel sampling
cylinder and a coil of copper tubing (Fig. 8) both of which are filled with
Type SA molecular sieve material. Since the cylinder is cooled by liquid
nitrogen (LN2 ), all gases except helium are trapped and the helium is pumped
off, after which the cylinder can be closed off and allowed to warm up for
storage prior to the gas sample being processed. The majority of oxygen,
water-vapor, and CO 2 are trapped in the cylinder where the cross sectional
area is sufficiently large to prevent "ice" blockage while the argon and any
nitrogen are primarily trapped in the copper tubing.
The final gas sample volume to be processed is approximately 30 liters,
regardless of the length of time used in collecting it.
3.2	 Discussion
The system has proven to be quite reliable and well-tolerated by patients
for up to six hours of continuous operation. The only long-term maintenance
required, besides renewing the soda lime and gas supplies, has been periodic
replacement of the bellows at about four-month intervals.
The use of a closed-circuit breathing system does raise the question of
reabsorption of previously exhaled 37 A into body tissues. Since the solubility
constants and diffusion rate constants for argon and nitrogen are similar (10),
we used data on nitrogen absorption during the uasign study for the rebreath-
ing system. Investigations of the rate of excretion from body tissues when the
atmosphere the patient is breathing is suddenly shifted from normal to one
with essentially no nitrogen content have been reported (11). The usual
result is that 80-90% of the absorbed nitrogen is released in three hours.
It
II
- 8 -
Based on the nitrogen data, our assumption was that by usirg ultra-pure gases
(argon content <0.01%) and a reasonably large volume in the rebreathing system
that the stable argon absorbed in the body (normally at equilibrium with
about 1% argon concentration in the atmosphere) will be rapidly excreted
from the body, minimizing reabsorption problems.
Three patients being studied for excretion rate measurements (12) were
irradiated twice over a period of about six months with breath samples
collected with an open circuit system on one irradiation and a closed-ciruit
system on the other. The patients selected did not have a significant change
of body weight between measurements. The excretion rates measured were the
same (within a range of + 5%) at each point in time for each patient. These	
11
results suggest that there was no significant reabsorption of 37 A in the	 I
closed-circuit system when it is loaded with essentially argon-free gas.
4.0 Gas Purification System
4.1	 Description of System
,
The purification system, a simplified diagram of which is shown in
Figure 9, is based on absorption of undesired gaseous products. Copper columns
maintained at 4000C and previously reduced by hydrogen absorb oxygen, columns
of soda lime, CaSO4
 and Aquasorb remove CO I
 and water vapor, after which remain-
ing gases are first trapped on Type 5A molecular sieve material while residual
helium is pumped off and then placed into a tube containing calcium at 6000C
to remove nitrogen. The last step is to transfer the sample into a 30 cc
proportional detector by means of a calibrated Toepler pump. The volume of
gas transferred is measured and then, using calibrated volumes, sufficient
stable rrgon and C114
 are transferred to bring the proportional counter gas to
a mixture of 90% Ar and 10% 011 4 at 1 atms, absolute.
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4.2	 Discussion
The entire purification procedure, including regeneration of the
copper columns, takes approximately five hours, although only intermittent
attention by a technician is required. The calcium furnace containing
550 g of calcium turnings, is sufficient for about 400 procedures before
replenishment and is the only long-term maintenance item besides normal
vacuum system upkeep and periodic replacement of the soda lime and CaSO4
cannisters.
The system being completely manually operated does require great
care in use to avoid inadvertent venting or contamination of the sample.
As indicated in a more detailed schematic of the system (Fig. 10), the	 f
technician must exercise considerable care in operation. Future implemen-
tations of the 37 A technique would benefit greatly from fully automating
the gas processing system.
5.0 37 A Counting System
5.1 Description of System
The proportional detector is placed between two 9" x 4" NaI(T1)
detectors which act as cosmic ray anti-coincidence shields and the entire
detector assembly is surrounded by four inches of lead (Fig. 11). The only
unusual feature of the electronics is the inclusion of a pulse shape analyzer
(Ortec Model 453) which is used to discriminate against noise based on the
rise time of the pulses. A typical 37 A spectrum is shown in Figure 12 along
with a spectrum of 55 Fewhich is used to set the amplifier gain.
Two basic designs are used for the proportional detectors (Fig. 13).
For the standard 37 A study (patient dose - 10 mrad) a 30 cc detector made
out of oxygen free copper tubing is used. The detectors have an inside
diameter of 15 mm with a wall thickness of 1.0 mm, Kovar feed troughs at the
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ends and a 0.0008 inch diameter gold-plated tungsten wire which is sec"A-ed
to the external portion of the seals with a silver-tin solder. A standard
MHO' connector is soldered to an extension on the copper tube and is also
soldered to one of the Kovar seals. In addition, a 0.001 inch thick tin
foil is soldered over a 3 mm hole in the center of the tube to allow the
detector to "see" the 55 Fe calibration source. The energy resolution of
55 FP is rvnirall y 177 and the back ground countine rate under the 37 A peak
is normally 0.1 cpm.
The second type of detector is used for multiple day counting. The
basic design is identical to the Type I detectors except that the tube
material is zone refined quartz glass and ultra-pure 0.0005 inch thick
copper foil and is used to line the inside of the tube. The energy spectrum
is the same as the first type of detector, but the background rate is
normally 0.03 cpm.
5.2	 Discussion
The system has proven to be quite reliable with the only major problem
encountered being the slow build up of tritium contamination inside the
detectors. Tile tritium, which is present in the Health Sciences environment,
causes a slow increase in background counting rates. Tile problem is controlled
through cyragenic trapping in the purification system and periodic pumpin,' of
the detectors with a titanium furnace (at 9050C) (7).
Potential applications of the 37 A systems to regional bone mass studies
on lowering the TBC dose to 1 mrad will require counting samples for 3 to 5
days. The counting system could be expanded to handle seven detectors contin-
uously, thus allowing a sample to be processed and placed in a detector for
counting at the rate of one per day. Design studies for such a system have
1	
been performed and discussed in recent reports (13).
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0	 6.0 Excretion Rate
6.1	 Measurement Technique
Sixteen patients who were undergoing serial examinations of body
calcium by the 49 Catechnique at the cyclotron facility were studied during
the early period of this research contract. The neutron beam produced at
the cyclotron facility has a mean energy of 8 MeV and a full width at half
maximum of 8 MeV and in these procedures, both the 48Ca(n,a) 49 Caand the
40Ca(n,a) 37 A reactions are produced in-vivo.
Argon-37 excretion was measured by taking several samples of the
exhaled breath at various times after irradiation. Continuous breath collec-
tions were not possible because the breath collection apparatus could not be
used during the three,12 minute total-body counting procedures after irradiation
49	 37(for	 Ca). The
	
Ar was processed and counted in early versions of the system
previously described in this report. The breath samples were typically 10
minutes long.
One additional volunteer was studiea For excretion rate at the 14 MeV
facility when it was operational. The procedures were essentially the same
as used at the cyclotron.
6.3	 Excretion Rate Data
The combined data is shown on Figure 14. The vertical axis indicates
the 37 A excretion as a rate normalized to the TBC of each patient as measured
independently by the 49 Casystem. The data indicate the maximum rate Gf 37 A
excretion occurs essentially immediately. By six hours post irradiation, the
rate has decreased to approximately 1% of the maximum value.
Figure 15 depicts the serial excretion rates from tl • cee individuals and is
typical of that seen in patients when three or more serial sawles are obtained.
^.J	 The data of Figure 15 represent the two extremes observed in the co-bined data
plot of Figure 14.
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6.3	 Discussion
The combined data can be described by a double exponential equation
as indicated in Figure 14. The fast component of the descending limb has a
T-1/2 of approximately 27 min. and the T-1/2 of the slow component is approxi-
mately 156 min. The individual data (Fig. 15) can be "fit" holding the T-1/2
values constant and adjusting the multiplicative constants of each exponential.
f'
Earlier analyses of this data (12) suggested that the fast T-1/2 values might
be related to the surface area of bone, i.e. primarily turbecula bone. However,
subsequent analyses has proven that such cannot be.the case since models based
on the excretion rate data and 37 A yields measured during studies to determine
the accuracy of the technique show that 81% of the 37 A released is in the
fast component and 18% is in the slow component (13). Since 90% of the surface
area of bone is contained in turbecula bone which in turn comprises about 20%
of total bone, the fast component could only contain 26% of the 37 A released
if the surface area theory was correct.
7.0 Accuracy of Measurement
	
7.1	 Measurement Technique
A study designed to determine the accuracy of the 37 A technique in
measuring total body calcium (TBC) in humans was initiated during this report-
ing period. The study is based on measuring the TBC of a patient with the
established 49 Casystem at the University of Washington and comparing the TBC
to the 37 A yield from the same patient after irradiation at the 14 MeV facility.
The original protocol required that the 37 A exhaled during the first hour,
the first three hours, and the first five hours post irradiation be quantitated
and compared to the 
49 
CaTBC. However, after the first few irradiations, it
1
i
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became clear that the 0-5 hour data will not be necessary since adequate
accuracy et, ae obtained with the shorter breath collection intervals. As
a result, the 0-5 hour collection period was generally not taken.
7.2	 .Accuracy Data
The study includes 10 normal volunteers and 4 osteoporotic patients
(with documented compression fractures). The average age of the normal group is
57 years, with only one volunteer less than 30 years old. The group includes
6 males and 4 females. The volunteers ranged in height from 155 cm to 183 cm;
in weight from 58.6 kg to 202.5 kg; and in TBC from 594 g to 1,137 g.
The data obtained to-date is listed in Table 1 and illustrated in Figure 16.
.,,
	
The data shows a strong correlation between 37Ar yield and TBC as measured using
the 
49 
Catechnique.
7.3
	
Discussion
The correlation between the 37 A yields and TBC as measured by the 49 Ca
technique is excellent (r = 0.96 for a one hour breath collection period,
r = 0.98 for a three hour breath collection period). The least squares linear
regression analysis describes the data well (the solid lines in Figure 16) and
provides a standard area of the estimate (the dashed lines in Figure 16) for
the regression which is within + 5%. Thus, the TBC as measured by the 
49 
Ca
technique can be predicted using the 37 A data to within + 5% (1 S.h.). The
predictability by the three hour breath collection data is slightly better
than the one hour data, as clearly shown by the data point spread in Figure 16.
For a one hour breath collection, the conversion of 37 A yield to TBC is:
TBC (kg) = 0.11 P 7Ar one hour yield in pCi] + 0.4.
For a three hour breath collection, the appropriate relation is:
0	 TBC (kg) = 0.086 E37 Ar three hour yields in pC J + 0.32.
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8.0 Precision of Measurement
Aoft
8.1	 Measurement Techniqu^_
A study to determine the precision of measurement of the 37 A TBC
system was undertaken. Six normal volunteers were irradiated, each three
times over approximately two weeks. The 0-1 and 0-3 hour 37 A yields were
measured using the standard TBC procedure.
	
8.2	 Precision Data
The 37 A yields were determined for each of the measurements of each
of the six volunteers. In order to combine the results from all six indi-
viduals, the mean yield for each of the three measurements for each indi-
vidual was calculated. The yields for each individual were then expressed
as the 37 A produced relative to the mean yield for that individual.
The volunteers included 4 females and 2 males, ranging in age from
M	 22 to 67 years old. The datais summarized in Table 2.
	
8.3	 Discussion
The precision of the technique is quite acceptable at + 3.32 (1 S.D.)
for a breath collection period of one hour and + 2.4% for a three hour breath
collection. The slightly better precision for the three hour breath collection
is most likely due to a combination of slightly better counting statistics
and less biological variation due to slight changes in the excretion rate
(see Section 6.2).
9.0 Summary and Discussion
	
9.1	 General
The systems have proven to be quite reliable with the only major
maintenance worry being the prevention of leaks, primarily in the rebreathing
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system due to normal wear of flexible joints and hoses. The question of
potential health risks due to patient dose of 10 mrad has also been evaluated
and found to be negligible (14).
The excellent correlation between the 37 A yield and TBC as measured
by the 49Ca system (r = 0.98, standard error of the estimate = + 5%) coupled
with the patient dose of 10 mrad meet the primary objective of this contract
to develop a low dose technique to accurately and precisely measure total
body calcium.
r...
9.2	 Factors Affecting Accuracy and Precision
^R.
In addition to the usual problems of biological variance and the
quality control of the collection and purification systems to prevent gas
leaks, there are three major areas of concern in utilizing the 37 A technique:
1) long-term trapping of 37 A in bone crystal; 2) the incomplete collection of
a^	 the 37 A released and the cause of the excretion rate hal`-lives; and 3) the
possibility of reabsorption of 37 A from rebreathing system back into fatty
tissues within the patient.
There have been several indications that some of the 37 A produced in-vivo
is retained (5,7,9,12,13). Estimates made by our group, H.E. Palmer,and others,
which are based upon the amount of 37 A obtained per gram of calcium from
irradiated solutions of calcium as compared to the amount of 37 A recovered
from in-vivo irradiations of human subjects, indicate that 10 to 307 of the
argon may be retained.
The accuracy data presented in Section 7 indicates that whatever retention
is present i, having no discernible effect on the application of the 37 A
`	 technique. Some data recently obtained at Sloan-Kettering Cancer Center gives
k
some indication of why retention is not a major problem. The data is an attempt
I
^ f
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at measuring percent Ar retention vs. age in bone removed from amputated
limbs. The experimental procedure involves sealing the "fresh" bone in a
glass container filled partially with water. The sample Is irradiated and
helium bubbled through the container. The 37 A then recovered is considered
as the normally released fraction. The bone is then dissolved and he2ted in
solution while helium is bubbled through. The 37 A recovered is considered
as the retained fraction. The normally released fraction, since it is still
determined via a totally in-vitro procedure, does not completely duplicate the
in-vivo process. However, the character of the change of percent 37 A retained
vs. age probably is representative of the in-vivo process.
The data is presented in Figure 17. A least squares fit to the data is
also plotted in the figure. An anlyses of this data (13) indicate that worse
possible "error" or change to be expected over a 50 year span if corrections
( ^	 are not made for retention is 4%. The conclusion is further verified by
L	 plotting the 37 A yields obtained in the accuracy study and correcting for
retention using the Bigler data. Such a plot is shown on Figure 18. While
the slope has changed, the standard error of the estimate is slightly worse,
and hence, corrections for long-term retention of 37 A are not necessary.
The second major concern, the incomplete collecting; of all the 37 A
which is released in-vivo, is only a problem if the excretion at any point
in time does not represent a uniform sampling of the body calcium, or if there
are extreme variances in the excretion rate curves between individuals. The
questions of the cause for the bio'ogical half-lives observed on the excretion
rate data remains unanswered, except that it does not arise from simple
trabecular and cortical bone compartments (Section 6). In view of the
excellent accuracy data (Section 7), it appears that the observed 37 A components
0	 are sampling the total body calcium rather uniformly.
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The only major concern regarding the use of 37 A is the possibility
of reabsorption of 37 A into the body from the circulating gases of the
rebreathing system. This question has already been discussed in detail in
Section 3.2, and based on the accuracy and precision data does not appear
to be a major factor.
Further support for this conclusion can be obtained by correlating 37 A
yields versus weight and body size. Analysis of this type yicid no correlation.
Since reabsorption would presumably be mere severe in "stout" individuals with
I	 more body fat, the lack of correlation would indicate that any reabsorption
has no observable effect.
However, a direct investigation of the reabsorption question is pl-finned
by direct measurement of the reabsorption of 41 A when introduced inti the
circulating atmosphere of the rebreathing system. Results of such measure-
if 	 ments are expected to ie published during 1978.
9.3	 Recommendations
The results of the accuracy and precision studies clearly indicate that
the 
37^: 
technique can be used to measure total body calci-im in humans. The
implementation of the system for large scale clinical studies or for research
into bone metabolism would benefit from development of an expanded purification
and counting system. The existing system has been assembled primarily as an
engineering developmental system, and not as a high use system. During the
past year and a half, no major changes in the design of the system have been
needed to analyze the patient data, although several revisions to decrease
f+ system down time would be desirable.
^
`	 r
1
We have designed a new purification system. 	 The basic system design will
be the same as the existing apparatus, but will include two complete purification
20 -
C, 	
systems with cross connections at each major component. Thus, if all components
are operational, two samples at a time can be processed. If part of one system
needs rcr3ir, two samples could still be processed by appropriate sharing of
system resources.
The new system would inciode provisions for the addition of automatic
valve activators, as well as pressure, flow and temperature sensors which would
allow the system to be run by a computer. Increasing throughput to four or
six samples a day could be accomplished, if needed.
Other improvements in the new system would include: 1) no tygon or other
"weak" vacuum materials will be used, 2) reduction of the copper columns will
be done automaticall y without removing the columns from the system, 3) the
addition of connection ports for the helium leak detector for preventive main-
tenance, 4) replacement of all brass valves and tubing with stainless steel
to prevent mercury-induced material failures, S) automatic liquid nitrogen
}	 level controllers for all dewars, and 6) a vacuum system providing higher
pumping speeds.
If a new purification system is built, the counting system will also
need to be expanded to handle the larger number of samples to be counted per
day. The multichannel analyzer should be provided with a gated router to
allow the collection of multiple spectra. Several more proportional detectors
should be fabricated and a new cosmic-ray anti-coincidence shield should be
fabricated to allow proper shielding of multiple proportional detectors. With
n	 a relatively modest expansion of the existing_ system, up to eight detectors
N
could be operated simultaneously. Typically, one of the detectors would be a
background monitor, while the remainder of the detectors would be available
'
	
	 for sample counting.
a_
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Support of research at sites other than the University of Washington
would be most efficiently implemented by installing activation facilities
at the selected sites (or develop a mobile activation facility on a trailer)
and sending the breath samples to the central processing and counting facility
at the University of Washington.
^j
A
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